Galmed Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:GLMD

Comments

Galmed Pharmaceuticals Ltd Earnings Estimates

GLMDNASDAQ

Trade with Public

$0.5710

-0.042-6.85%

At close: Feb 17, 4:00 PM EST

$0.6001

0.02915.10%

After Hours: Feb 13, 9:20 AM EST

Overview NewsEarningsAnalyst Ratings Short Interest Stock Report

Galmed Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:GLMD

Galmed Pharmaceuticals (GLMD) is scheduled to report Q4 earnings on April 1, 2026. Analysts estimate EPS of $-0.51 and quarterly revenue of N/A.

In the most recent quarter (Q3), Galmed Pharmaceuticals reported EPS of $-0.33, beating estimates of $-0.54 by 0.39%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Galmed Pharmaceuticals has beaten EPS estimates in 2 consecutive quarters.

Over the last 4 quarters, Galmed Pharmaceuticals has averaged an EPS surprise of 0.72% and a revenue surprise of 0.00%.

Earnings Date

Apr 1

EPS Estimate

$-0.510

Quarterly Revenue Estimate

–

Annual Revenue
(as of Sep 30)

–

Galmed Pharmaceuticals Earnings History

Analyze the earnings history of Galmed Pharmaceuticals using advanced sorting and filters.

												Get Alert
GLMD	Galmed Pharmaceuticals	Q4	-$0.85	-$0.51	—	—	$0.00	—	—	—	04/01/2026	Get Alert
GLMD	Galmed Pharmaceuticals	Q3	-$2.31	-$0.54	-$0.33	38.89%	$0.00	—	$0.00	—	11/26/2025	Get Alert
GLMD	Galmed Pharmaceuticals	Q2	-$1.65	-$0.79	-$0.63	24.10%	$0.00	—	$0.00	—	08/28/2025	Get Alert
GLMD	Galmed Pharmaceuticals	Q1	-$2.10	—	-$0.62	—	$0.00	—	$0.00	—	05/22/2025	Get Alert
GLMD	Galmed Pharmaceuticals	Q4	-$11.76	—	-$0.85	—	$0.00	—	$0.00	—	04/02/2025	Get Alert
GLMD	Galmed Pharmaceuticals	Q3	-$3.43	—	-$2.31	—	$0.00	—	$0.00	—	11/14/2024	Get Alert
GLMD	Galmed Pharmaceuticals	Q2	-$11.40	—	-$2.16	—	$0.00	—	$0.00	—	08/28/2024	Get Alert
GLMD	Galmed Pharmaceuticals	Q1	-$13.08	—	-$2.76	—	$0.00	—	$0.00	—	05/30/2024	Get Alert
GLMD	Galmed Pharmaceuticals	Q4	-$18.00	-$3.84	-$11.76	-206.25%	$0.00	—	$0.00	—	04/04/2024	Get Alert
GLMD	Galmed Pharmaceuticals	Q3	-$37.80	-$3.60	-$2.88	20.00%	$0.00	—	$0.00	—	11/22/2023	Get Alert
GLMD	Galmed Pharmaceuticals	Q2	-$27.00	-$4.08	-$11.40	-179.41%	$0.00	—	$0.00	—	08/09/2023	Get Alert
GLMD	Galmed Pharmaceuticals	Q1	-$43.20	-$18.00	-$13.08	27.33%	$0.00	—	$0.00	—	06/01/2023	Get Alert
GLMD	Galmed Pharmaceuticals	Q4	-$54.00	-$25.20	-$18.00	28.57%	$0.00	—	$0.00	—	03/29/2023	Get Alert
GLMD	Galmed Pharmaceuticals	Q3	-$55.80	-$28.80	-$37.80	-31.25%	$0.00	—	$0.00	—	11/16/2022	Get Alert
GLMD	Galmed Pharmaceuticals	Q2	-$59.40	-$43.20	-$27.00	37.50%	$0.00	—	$0.00	—	08/04/2022	Get Alert
GLMD	Galmed Pharmaceuticals	Q1	-$68.40	-$57.60	-$43.20	25.00%	$0.00	—	$0.00	—	05/17/2022	Get Alert
GLMD	Galmed Pharmaceuticals	Q4	-$86.40	-$54.00	-$54.00	0.00%	$0.00	—	$0.00	—	05/02/2022	Get Alert
GLMD	Galmed Pharmaceuticals	Q3	-$57.60	-$64.80	-$55.80	13.89%	$0.00	—	$0.00	—	11/08/2021	Get Alert
GLMD	Galmed Pharmaceuticals	Q2	-$46.80	-$68.40	-$59.40	13.16%	$0.00	—	$0.00	—	08/05/2021	Get Alert
GLMD	Galmed Pharmaceuticals	Q1	-$52.20	-$70.20	-$68.40	2.56%	$0.00	—	$0.00	—	05/13/2021	Get Alert
GLMD	Galmed Pharmaceuticals	Q4	-$70.20	-$64.80	-$86.40	-33.33%	$0.00	—	$0.00	—	03/18/2021	Get Alert

Galmed Pharmaceuticals (GLMD) Earnings Per Share

The chart below shows Galmed Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.

Quarterly Earnings Surprise Amount

Fiscal Quarter	Date Reported	Actual EPS	Estimated EPS	Surprise %
Q3	2025-11-26	$-0.33	$-0.54	38.9 %
Q2	2025-08-28	$-0.63	$-0.79	24.1 %
Q4	2024-04-04	$-11.76	$-3.84	-206.3 %
Q3	2023-11-22	$-2.88	$-3.60	20.0 %

Galmed Pharmaceuticals (GLMD) Revenue

The chart below shows Galmed Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Galmed Pharmaceuticals (NASDAQ:GLMD) reporting earnings?

Galmed Pharmaceuticals (GLMD) is scheduled to report earnings on April 1, 2026. The last reported earnings were for reported on November 26, 2025 for Q3.